Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

<< Previous

Bullboard Posts

Next >>

Post by biorunon Nov 02, 2022 8:50pm

159 Views

Post# 35068447

Shock the Monkey

Shocker, you give me too much attention. Buy or don't buy, these prices are decent. Really don't care. Maybe HCD can get you to sell desperately...and you can buy back lower.. lol.

Your post is incoherent. Do you actually know what a Shocker is? Nice handle. I sense you don't otherwise it wouldn't be your handle.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments